Bloodwise's blog posts
New study could help tailor treatment for most common type of leukaemia
New findings by scientists at the University of Southampton could help to predict how people with the most common form of leukaemia will respond to chemotherapy.
Targeted cancer drug made available to mantle cell lymphoma patients on NHS
We welcome today’s announcement by NICE that the drug ibrutinib will be made available on the NHS in England to people with mantle cell lymphoma who relapse or do not respond to treatment
How to crack Christmas with cancer
Preparing for Christmas can be exhausting at the best of times, but if you’re experiencing fatigue and other symptoms or side effects of blood cancer, it can feel anything but festive. We asked our very own Christmas crackers, the Bloodwise ambassadors, for their top tips on coping with (and enjoying!) Christmas, wherever you’re celebrating it.
New drug combination for leukaemia shows highly promising results in clinical trial
Results of a UK clinical trial suggest a combination of two targeted drugs could be highly effective in treating chronic lymphocytic leukaemia
Clinical trial reveals genetic fault that reduces the effectiveness of leukaemia treatment
A genetic fault has been identified in people with an aggressive type of leukaemia that can significantly affect how they respond to treatment.